Corcept Therapeutics (CORT) rebounded from its 50-day moving average after third-quarter results on Oct. 30 and reached an all-time high before building a base. Now, the stock is nearing a buy point of 62.22 in a cup base, making the medical stock Wednesday's selection for IBD 50 Stocks To Watch. One other positive for investors is that shares rebounded from…

Sign In

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.